Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling

P. J. Barnes (London, United Kingdom)

Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside
Session: PG1 - Asthma: from bench to bedside
Session type: Postgraduate Course
Number: 2
Disease area: Airway diseases

Slide presentationPDF journal article, handout or slidesMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. J. Barnes (London, United Kingdom). Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling. Annual Congress 2007 - PG1 - Asthma: from bench to bedside

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Airway inflammatory mediators and airway wall remodelling in asthma
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009



The role of CCR5 in allergen-induced airway hyperresponsiveness and airway inflammation
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009

Anti-cytokine approaches should target bronchial hyperresponsiveness rather than inflammation – Pro
Source: Annual Congress 2006 - Pro/Con: asthma is (not) an inflammatory disease
Year: 2006


Role of IL-33 signaling in pollutant-induced allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018


Allergen-induced airway remodelling
Source: Eur Respir J 2007; 29: 1020-1032
Year: 2007



Corticosteroid-resistant neutrophilic airway inflammation and hyperresponsiveness caused by IL-13
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

Modulation of ozone-induced airway hyperresponsiveness and inflammation by interleukin-13
Source: Eur Respir J 2008; 32: 571-578
Year: 2008



Increased arginase activity contributes to airway remodelling in chronic allergic asthma
Source: Eur Respir J 2011; 38: 318-328
Year: 2011



Role of leukotrienes in airway inflammation
Source: Annual Congress 2004 - Early management of inflammatory airway diseases - Can we do better?
Year: 2004

Effect of bronchial neutrophilia on airway remodeling in asthma
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008

The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007


Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats
Source: Eur Respir J 2006; 27: 726-734
Year: 2006



ILC2s in allergic airway inflammation
Source: International Congress 2014 – Highlights from the Lung Science Conference 2014
Year: 2014



ADAM-8 metalloproteinase drives acute allergen-induced airway inflammation
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Effect of neutrophil elastase inhibitor on airway inflammation and airway hyperresponsiveness in a murine model of asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


Allergen-induced airway responses
Source: Eur Respir J 2015; 46: 819-831
Year: 2015



Arginase in airway inflammation and remodelling
Source: Annual Congress 2004 - Arginase: a novel target and marker for asthma?
Year: 2004